Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer

doi:10.4251/wjgo.v14.i6.1162

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3303)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

169

WORD

101

HTML

1547

Figures (1-2)

209

Tables (1-5)

188

Sum=2214

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

295

Download

794

Sum=1089

Jun 15, 2022 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jun 15, 2022; 14(6): 1162-1174
Published online Jun 15, 2022. doi: 10.4251/wjgo.v14.i6.1162

Full Size Figure Download Figure

Figure 1 Intestinal-type gastric cancer. A: Recurrence score; B: Cancer-specific death score. Kaplan-Meier curves of each prognostic group (S1-S4). P value by log-rank test was P < 0.001.

Citation: Díaz del Arco C, Estrada Muñoz L, Ortega Medina L, Molina Roldán E, Cerón Nieto MÁ, García Gómez de las Heras S, Fernández Aceñero MJ. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer. World J Gastrointest Oncol 2022; 14(6): 1162-1174
URL: https://www.wjgnet.com/1948-5204/full/v14/i6/1162.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i6.1162